CAFC Affirms Patent Validity for Eli Lilly's Diabetes Drug
cafc · 2026-04-16 · Defendant Win · Impact: 30/100
Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company, decided by Federal Circuit on April 16, 2026, resulted in a defendant win outcome. The case concerns the validity of a patent held by ...
CAFC Affirms PTAB's Non-Obviousness Finding for Sound View Patent
cafc · 2026-01-29 · Plaintiff Win · Impact: 25/100
Sound View Innovations, LLC v. Hulu, LLC, decided by Federal Circuit on January 29, 2026, resulted in a plaintiff win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) d...
CAFC Affirms PTAB Decision, Upholding Seagen's Cancer Drug Patent
cafc · 2025-12-02 · Defendant Win · Impact: 30/100
Seagen Inc. v. Daiichi Sankyo Company, Ltd., decided by Federal Circuit on December 2, 2025, resulted in a defendant win outcome. The core dispute centered on whether Daiichi Sankyo's patent for a can...
Federal Circuit Affirms Non-Infringement of Semiconductor Manufacturing Patent
cafc · 2025-10-15 · Defendant Win · Impact: 25/100
Iqe Plc v. Newport Fab, LLC, decided by Federal Circuit on October 15, 2025, resulted in a defendant win outcome. The case concerns whether a patent for a "method of manufacturing a semiconductor devi...
Federal Circuit Affirms PTAB's Obviousness Finding for Patent Claims
cafc · 2025-08-26 · Defendant Win · Impact: 25/100
In Re BRUNETTI, decided by Federal Circuit on August 26, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decision that claims of Brun...
Federal Circuit Affirms PTAB Obviousness Finding in Semiconductor Patent Case
cafc · 2025-08-12 · Defendant Win · Impact: 30/100
Fisher v. United States, decided by Federal Circuit on August 12, 2025, resulted in a defendant win outcome. The case concerns whether the Patent Trial and Appeal Board (PTAB) correctly applied the "o...
Federal Circuit Affirms PTAB's Non-Obviousness Finding for IGT Patents
cafc · 2025-07-22 · Defendant Win · Impact: 20/100
Igt v. Zynga Inc., decided by Federal Circuit on July 22, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decision that claims of IGT...
CAFC Affirms Obviousness Rejection of Semiconductor Manufacturing Patent
cafc · 2025-06-27 · Defendant Win · Impact: 20/100
Deal v. Collins, decided by Federal Circuit on June 27, 2025, resulted in a defendant win outcome. The case concerns whether a patent claim for a "method of manufacturing a semiconductor device" was p...
Federal Circuit Affirms Non-Infringement Finding in X-Ray Microscopy Patent Case
cafc · 2025-05-23 · Defendant Win · Impact: 15/100
Sigray, Inc. v. Carl Zeiss X-Ray Microscopy, Inc., decided by Federal Circuit on May 23, 2025, resulted in a defendant win outcome. The case concerns a patent dispute over a "method for inspecting a s...
Federal Circuit Affirms PTAB Finding of Obviousness for JAK Inhibitor Patents
cafc · 2025-05-07 · Defendant Win · Impact: 30/100
Incyte Corporation v. Sun Pharmaceutical Industries, Inc., decided by Federal Circuit on May 7, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Boar...
CAFC Affirms Non-Infringement of Point-of-Sale Terminal Patent
cafc · 2025-05-07 · Defendant Win · Impact: 15/100
Ingenico Inc. v. Ioengine, LLC, decided by Federal Circuit on May 7, 2025, resulted in a defendant win outcome. The core dispute centered on whether Ioengine's "smart card" technology infringed Ingeni...
Federal Circuit Affirms PTAB Obviousness Finding for Sage Products Patent
cafc · 2025-04-15 · Defendant Win · Impact: 30/100
Sage Products, LLC v. Stewart, decided by Federal Circuit on April 15, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) decision that ...
CAFC Affirms Patentability of Merck's Method of Treatment Patent
cafc · 2025-03-10 · Defendant Win · Impact: 20/100
Cqv Co., Ltd. v. Merck Patent Gmbh, decided by Federal Circuit on March 10, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for a "method of treating" a ...